MAGE, BAGE and GAGE: Tumour antigen expression in benign and malignant ovarian tissue

British Journal of Cancer

Volumn 78, Issue 6, 1998, Pages 816-821

  Gillespie, A M ^a,d   Rodgers, S ^a   Wilson, A P ^b   Tidy, J ^a   Rees, R C ^c   Coleman, R E ^a   Murray, A K ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b DERBY CITY GENERAL HOSPITAL   (United Kingdom)

^c NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^d WESTON PARK HOSPITAL   (United Kingdom)

Author keywords

BAGE; Cancer immunotherapy; GAGE; MAGE; Ovarian; Tumour antigen

Indexed keywords

BAGE PEPTIDE; DIGOXIGENIN; ETHIDIUM BROMIDE; GAGE PEPTIDE; MAGE PEPTIDE; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CYSTADENOCARCINOMA; CYSTADENOMA; ENDOMETRIOSIS; FEMALE; FIBROMA; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OLIGONUCLEOTIDE PROBE; OVARY CANCER; OVARY TUMOR; PREMENOPAUSE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031708228     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.585     Document Type: Article

References (29)

1. Berek JS and Martinez-Maza O (1995) Immunology and immunotherapy of ovarian cancer. In Epithelial Cancer of the Ovary, Lawton FG, Neijt JP and Swenerton KD (eds) pp. 220-247. BMJ Publishing Group: London
2. Boel P, Wildmann C, Sensi ML, Brasseur R, Renauld JC, Coulie P, Boon T, Van Der Bruggen P (1995) BAGE: a new gene encoding an antigen recognised on human melanomas by cytolytic T lymphocytes. Immunity 2: 167-175
3. Brasseur F, Marchand M, Vanwijck R, Hérin M, Lethé B, Chomez P, and Boon T (1992) Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int J Cancer 52: 839-841
4. Brasseur F, Rimoldi D, Liénard D, Lethé B, Carrel S, Arienti F, Suter L, Vanwijck R, Bourlond A, Humblet Y, Vacca A, Conese M, Lahaye T, Degiovanni G, Deraemaecker R, Beauduin M, Sastre X, Salamon E, Dréno B, Jager E, Knuth A, Chevreau C, Suciu S, Lachapelle J-M, Pouillart P, Parmiani G, Lejeune F, Cerottini J-C, Boon T and Marchand M (1995) Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer 63: 375-380
5. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora J-P, De Smet C, Brasseur F, Van Der Bruggen P, Lethe B, Lurquin C, Brasseur R, Chomez P, de Backer O, Cavenee W and Boon T (1994) Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40: 360-369
6. De-Smet C, De-Backer O, Faraoni I, Lurquin C, Brasseur F and Boon T (1996) The activation of human gene MAGE-1 in tumour cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 93(14) 7149-7153
7. Finke J, Fritzen R, Ternes P, Lange W and Dolken G (1993) An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR. BioTechniques 14: 448-453
8. Gaugler B, Van Den Eynde B, Van Der Bruggen P, Romero P, Gaforio JJ, De Plaen E, Lethé B, Brasseur F and Boon T (1994) Human gene MAGE-3 codes for an antigen recognised on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179: 921-930
9. Hacker NF, Berek JS, Lagasse LD, Nieberg RK and Elashoff RM (1983) Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynaecol 61: 413-420
10. Hulka B (1988) Cancer screening: degrees of proof and practical application. Cancer 62: 1776-1780
11. Inoue H, Li J, Honda M, Nakashima H, Shibuta K, Arinaga S, Ueo H, Mori M and Akiyoshi T (1995) MAGE-1 mRNA expression in gastric carcinoma. Int J Cancer (Pred Oncol) 64: 76-77
12. Marchand M, Weynants P, Rankin E, Arienti F, Belli F, Parmiani G, Cascinelli N, Bourlond A, Vanwijck R, Humblet Y, Canon JL, Laurent C, Naeyaert JM, Plagne R, Deramaeker R, Knuth A, Jaeger E, Brasseur F, Herman J, Coulie PG and Boon T (1995) Tumor regression responses in melanoma patients treated with a peptide encode by gene MAGE-3. Int J Cancer 63: 883-885
13. Mori M, Inoue H, Mimori K, Shibuta K, Baba K, Nakashima H, Haraguchi M, Tsuji K, Ueo H, Barnard GF and Akiyoshi T (1996) Expression of MAGE genes in human colorectal carcinoma. Ann Surg 224(2): 183-188
14. Mulchahy KA, Rimoldi D, Brasseur F, Rodgers S, Lienard D, Marchand M, Rennie IG, Murray AK, McIntyre CA, Platts KE, Leyvraz S, Boon T and Rees RC (1996) Infrequent expression of the MAGE gene family in uveal melanomas. Int J Cancer 66: 738-742
15. Office of Population Censuses and Surveys (1993) Mortality statistics: cause (England and Wales) 1991. OPCS series DHZ, No. 18. London: HMSO
16. Patard J-J, Brasseur F, Gil-Diez S, Radvanyi F, Marchand M, Francois P, Abi-Aad A, Van Cangh P, Abbou CC, Chopin D and Boon T (1995) Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer (Pred Oncol) 64: 60-64
17. Petterson F (ed.) (1990) Annual report on the results of treatment in gynaecological cancer. Int J Gynaecol Obstet 44: 1776-1780
18. Russo V, Dalerba P, Ricci A, Bonazzi C, Leone BE, Mangioni C, Allavena P, Bordignon C and Traversari C (1996) MAGE, BAGE and GAGE genes expression in fresh epithelial ovarian carcinomas. Int J Cancer 67: 457-460
19. Schichijo S, Yamada A, Sagawa K, Iwamoto O, Sakata M, Nagai K and Itoh K (1996) Induction of MAGE genes in lymphoid cells by the demethylating agent 5-aza-2′-deoxycytidine. Jpn J Cancer Res 87(7): 751-756
20. Takahashi K, Shichijo S, Noguchi M, Hirohata M and Itoh K (1995) Identification of MAGE-1 and MAGE-4 proteins in spermatogomin and primary spermatocytes of testis. Cancer Res 55(16): 3478-3482
21. Traversari C, Van Der Bruggen P, Luescher IF, Lurquin C, Chomez P, Van Pel A, De Plaen E, Amar-Costesec A and Boon T (1992) A nonapeptide encoded by human gene MAGE-1 is recognised on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 176: 1453-1457
22. Van Den Eynde B, Peeters O, De-Backer O, Gaugler B, Lucas S and Boon T (1995) A new family of genes coding for an antigen recognised by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 182(3): 689-698
23. Van Der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van Den Eynde B, Knuth A and Boon T (1991) A gene encoding an antigen recognised by cytolytic T lymphocytes on a human malanoma. Science 254: 1643-1647
24. Van Der Bruggen P, Szikora J-P, Boel P, Wildmann C, Somville M, Sensi M and Boon T (1994a) Autologous cytolytic T lymphocytes recognise a MAGE-1 nonapeptide on melanomas expressing HLA-Cw(*)1601. Eur J Immunol 24: 2134-2140
25. Van Der Bruggen P, Bastin J, Gajewski T, Coulie PG, Boel P, De Smet C, Traversari C, Townsend A and Boon T (1994b) A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognise tumour cells expressing MAGE-3. Eur J Immunol 24: 308-3043
26. Van Der Burg MEL, Van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, Lacave AJ, Nardi M, Penard J, Pecorelli S (1995) The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. An EORTC Gynaecological Cancer Co-operative Group study. N Engl J Med 332(10): 629-634
27. Weber J, Salgaller M, Samid D, Johnson B, Herlyn M, Lassam N, Treisman J and Rosenberg SA (1994) Expression of MAGE-1 tumor antigen as up-regulated by the demethylating agent 5-aza-2′-deoxycytidine. Cancer Res 54(7): 1766-1771
28. Weynants P, Lethé B, Brasseur F, Marchand M and Boon T (1994) Expression of MAGE genes by non-small-cell lung carcinomas. Int J Cancer 56: 826-829
29. Yamada A, Kataoka A, Shichijo S, Kamura T, Imai Y, Nishida T and Itoh K (1995) Expression of MAGE-1, MAGE-2, MAGE-3/-6 and MAGE-4a/4b genes in ovarian tumours. Int J Cancer (Pred Oncol) 64: 388-393